mTOR — ìèøåíü ðàïàìèöèíà â êëåòêàõ ìëåêîïèòàþùèõ (mammalian target ofrapamycin)
NB! — âàæíî, îáðàòèòü âíèìàíèå (Nota bene)
NCI — Íàöèîíàëüíûé èíñòèòóò ðàêà (National Cancer Institute)
NICE — Íàöèîíàëüíûé èíñòèòóò çäîðîâüÿ è êëèíè÷åñêîãî ñîâåðøåíñòâîâàíèÿ (êà÷åñòâà ìåäèöèíñêîé ïîìîùè) Âåëèêîáðèòàíèè (National Institute for Health and Clinical Excellence)
NK — åñòåñòâåííûå êëåòêè-êèëëåðû (natural killer)
NMDA — N-ìåòèë-D-àñïàðòàò (N-methyl-D-aspartate)
NMDA — N-ìåòèë-D-àñïàðòàòíûå ðåöåïòîðû
NNT — ÷èñëî áîëüíûõ, êîòîðûõ íåîáõîäèìî ïðîëå÷èòü, ÷òîáû äîñòè÷ü êàêîãî-òî óêàçàííîãî ýôôåêòà (Number Need to Treatment)
OR — îòíîøåíèå øàíñîâ (odds ratio)
paCO2 — ïàðöèàëüíîå äàâëåíèå óãëåêèñëîãî ãàçà â àðòåðèàëüíîé êðîâè
PALS — êóðñû ðàñøèðåííûõ ðåàíèìàöèîííûõ ìåðîïðèÿòèé â ïåäèàòðèè (Pediatric Advanced Life Support)
PANDAS — àóòîèììóííîå íåéðîïñèõèàòðè÷åñêîå ðàññòðîéñòâî â äåòñêîì âîçðàñòå, àññîöèèðîâàííîå ñî ñòðåïòîêîêêîâîé èíôåêöèåé (Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection)
SD — ñòàíäàðòíîå îòêëîíåíèå (standart deviation) SEER — ýïèäåìèîëîãèÿ ýïèäíàäçîðà è äàííûõ î êîíå÷íûõ ðåçóëüòàòàõ (Surveillance Epidemiology and End Result)
American College of Obstetricians and Gynecologists: Fractional laser treatment of vulvovaginal atrophy and U.S. Food and Drug Administration clearance: position statement. 2016.
American College of Obstetricians and Gynecologists: Compounded bioidentical menopausal hormone therapy. Committee Opinion No. 532, August 2012, Reaffirmed 2018a
American College of Obstetricians and Gynecologists: Hormone therapy and heart disease. Committee Opinion No. 565, June 2013, Reaffirmed 2018b
American College of Obstetricians Gynecologists: Management of menopausal symptoms. Practice Bulletin No. 141, January, 2014, Reaffirmed 2018c
American College of Obstetricians and Gynecologists: Osteoporosis. Practice Bulletin No. 129, September 2012, Reaffirmed 2019a
American College of Obstetricians and Gynecologists: Use of antim?llerian hormone in women not seeking fertility care. Committee Opinion No. 773, March 2019b
Anastasilakis AD, Polyzos SA, Makras P, et al: Clinical features of 24 patients with rebound-associated vertebral fractures after denosumab discontinuation: systematic review and additional cases. J Bone Miner Res 32(6):1291, 2017
Anderson GL, Judd HL, Kaunitz AM, et al: Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women’s Health Initiative randomized trial. JAMA 290(13):1739, 2003
Anderson GL, Limacher M, Assaf AR, et al: Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA 291(14):1701, 2004
Arias E, Xu J, Kochanek KD: United States Life Tables, 2016. Natl Vital Stat Rep 68(4):1, 2019
Avis NE, Crawford SL, Greendale G, et al: Study of women’s health across the nation. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med 175(4):531, 2015
Avis NE, Levine BJ, Danhauer S, et al: A pooled analysis of three studies of nonpharmacological interventions for menopausal hot flashes. Menopause 26(4):350, 2019
Avis NE, Stellato R, Crawford S, et al: Is there an association between menopause status and sexual functioning? Menopause 7:297, 2000
Bachmann GA: Menopausal vasomotor symptoms: a review of causes, effects and evidence-based treatment options. J Reprod Med 50:155, 2005
Baker FC, Lampio L, Saaresranta T, et al: Sleep and sleep disorders in the menopausal transition. Sleep Med Clin 13(3):443, 2018
Ballinger CB: Psychiatric aspects of the menopause. Br J Psychiatry 156:773, 1990
Barber MD, Visco AG, Wyman JF, et al: Sexual function in women with urinary incontinence and pelvic organ prolapse. Obstet Gynecol 99:281, 2002
Barrett-Connor E, Siris ES, Wehren LE, et al: Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res 20(2):185, 2005
Bar-Shavit Z: The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell. J Cell Biochem 102(5):1130, 2007
Barzel US, Massey LK: Excess dietary protein can adversely affect bone. J Nutr 128(6):1051, 1998
Baumgartner RN, Heymsfield SB, Roche AF: Human body composition and the epidemiology of chronic disease. Obes Res 3:73, 1995
Bertone-Johnson ER, Manson JE, Purdue-Smithe AC, et al: Anti-M?llerian hormone levels and incidence of early natural menopause in a prospective study. Hum Reprod 33(6):1175, 2018
Bhatia NN, Bergman A, Karram MM: Effects of estrogen on urethral function in women with urinary incontinence. Am J Obstet Gynecol 160:176, 1989
Bhupathiraju SN, Grodstein F, Rosner BA, et al: Hormone therapy use and risk of chronic disease in the Nurses’ Health Study: a comparative analysis with the Women’s Health Initiative. Am J Epidemiol 186(6):696, 2017
Bhupathiraju SN, Grodstein F, Stampfer MJ, et al: Vaginal estrogen use and chronic disease risk in the Nurses’ Health Study. Menopause 26(6):603, 2018
Black DM, Cummings SR, Karpf DB, et al: Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348(9041):1535, 1996
Black DM, Schwartz AV, Ensrud KE, et al: Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA 296(24):2927, 2006
Blau LA, Hoehns JD: Analgesic efficacy of calcitonin for vertebral fracture pain. Ann Pharmacother 37(4):564, 2003
Bolland MJ, Barber PA, Doughty RN, et al: Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 336(7638):262, 2008
Bone HG, Hosking D, Devogelaer JP, et al: Ten years’ experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350(12):1189, 2004
Bone HG, Wagman RB, Brandi ML, et al: 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. Lancet Diabetes Endocrinol 5(7):513, 2017
Bonjour JP, Chevalley T, Ammann P, et al: Gain in bone mineral mass in prepubertal girls 3.5 years after discontinuation of calcium supplementation: a follow-up study. Lancet 358:1208, 2001
Braunstein GD: Safety of testosterone treatment in postmenopausal women. Fertil Steril 88(1):1, 2007
Brincat MP, Baron YM, Galea R: Estrogens and the skin. Climacteric 8(2):110, 2005
Broer SL, Broekmans FJ, Laven JS, et al: Anti-M?llerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update 20(5):688, 2014
Bromberger JT, Kravitz HM, Chang YF, et al: Major depression during and after the menopausal transition: Study of Women’s Health Across the Nation (SWAN). Psychol Med 41(9):1879, 2011
Burger HG, Dudley EC, Cui J, et al: A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 85:2832, 2000
Busch CM, Zonderman AB, Costa PT Jr: Menopausal transition and psychological distress in a nationally representative sample: is menopause associated with psychological distress? J Aging Health 6:206, 1994
Calleja-Agius J, Brincat MP: Effects of hormone replacement therapy on connective tissue: why is this important? Best Pract Res Clin Obstet Gynaecol 23(1):121, 2009
Camacho PM, Petak SM, Binkley N, et al: American Association Of Clinical Endocrinologists and American College Of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis— 2016. Endocr Pract 22(9):1111, 2016
Canalis E, Giustina A, Bilezikian JP: Mechanisms of anabolic therapies for osteoporosis. N Engl J Med 357(9):905, 2007
Canonico M. Hormone therapy and hemostasis among postmenopausal women: a review. Menopause 21(7):753, 2014
Canonico M, Scarabin PY. Oral versus transdermal estrogens and venous thromboembolism in postmenopausal women: what is new since 2003? Menopause 23(6):587, 2016
Carter ND, Khan KM, McKay HA, et al: Community-based exercise program reduces risk factors for falls in 65- to 75-year-old women with osteoporosis: randomized controlled trial. CMAJ 167(9):997, 2002
Chapuy MC, Arlot ME, Duboeuf F, et al: Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 327(23):1637, 1992
Christiansen C, Chesnut CH 3rd, Adachi JD, et al: Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosis. BMC Musculoskelet Disord 11:130, 2010
Cintron D, Lipford M, Larrea-Mantilla L, et al: Efficacy of menopausal hormone therapy on sleep quality: systematic review and meta-analysis. Endocrine 55(3):702, 2017
Clayton AH, Goldstein I, Kim NN, et al: The International Society for the Study of Women’s Sexual Health process of care for management of hypoactive sexual desire disorder in women. Mayo Clin Proc 93(4):467, 2018
Cody JD, Jacobs ML, Richardson K, et al: Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev 10:CD001405, 2012
Cohen FJ, Lu Y: Characterization of hot flashes reported by healthy postmenopausal women receiving raloxifene or placebo during osteoporosis prevention trials. Maturitas 34(1):65, 2000
Cohen LS, Soares CN, Vitonis AF, et al: Risk of new onset of depression during the menopausal transition: the Harvard Study of Moods and Cycles. Arch Gen Psychiatry 63(4):385, 2006
Constantine GD, Simon JA, Pickar JH, et al: The REJOICE trial: A phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophy. Menopause 24(4):409, 2017
Cosman F, de Beur SJ, LeBoff MS, et al: Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359, 2014
Cosman F, Miller PD, Williams GC, et al: Eighteen months of treatment with subcutaneous abaloparatide followed by 6 months of treatment with alendronate in postmenopausal women with osteoporosis: results of the ACTIVExtend trial. Mayo Clin Proc 92(2):200, 2017
Cosman FN, Crittenden DB, Adachi JD, et al: Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375(16):1532, 2016
Crandall CJ, Crawford SL, Gold EB: Vasomotor symptom prevalence is associated with polymorphisms in sex steroid-metabolizing enzymes and receptors. Am J Med 119:552, 2006
Crandall CJ, Hovey KM, Andrews CA, et al: Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women’s Health Initiative Observational Study. Menopause 25(1):11, 2018
Crandall CJ, Manson JE, Hohensee C, et al: Association of genetic variation in the tachykinin receptor 3 locus with hot flashes and night sweats in the women’s health initiative study. Menopause 24:252, 2017
Crawford SL, Crandall CJ, Derby CA, et al: Menopausal hormone therapy trends before versus after 2002: impact of the Women’s Health Initiative Study Results. Menopause 26(6):588, 2018
Creidi P, Faivre B, Agache P, et al: Effect of a conjugated oestrogen (Premarin) cream on ageing facial skin. A comparative study with a placebo cream. Maturitas 19(3):211, 1994
Cruz VL, Steiner ML, Pompei LM, et al: Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women. Menopause 25(1):21, 2018
Cummings SR, Nevitt MC, Browner WS, et al: Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332:767, 1995
Da Fonseca AM, Bagnoli VR, Souza MA, et al: Impact of age and body mass on the intensity of menopausal symptoms in 5968 Brazilian women. Gynecol Endocrinol 29(2):116, 2013
Daily JW, Ko BS, Ryuk J, et al: Equol decreases hot flashes in Postmenopausal Women: a systematic review and meta-analysis of randomized clinical trials. J Med Food 22(2):127–139, 2019.
Dallman MF, la Fleur SE, Pecoraro NC, et al: Minireview: glucocorticoids— food intake, abdominal obesity, and wealthy nations in 2004. Endocrinology 145:2633, 2004
Davis SR: Androgen use for low sexual desire in midlife women. Menopause 20(7):795, 2013
Davis SR, Baber R, Panay N, et al: Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab 104(10):4660, 2019
Davis SR, Braunstein GD: Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. J Sex Med 9(4):1134, 2012
Dawson-Hughes B, Harris SS: Calcium intake influences the association of protein intake with rates of bone loss in elderly men and women. Am J Clin Nutr 75(4):773, 2002
Dawson-Hughes B, Harris SS, Krall EA, et al: Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337(10):670, 1997
Delaney MF: Strategies for the prevention and treatment of osteoporosis during early postmenopause. Am J Obstet Gynecol 194(2 Suppl):S12, 2006
Dell RM, Adams AL, Greene DF, et al: Incidence of atypical nontraumatic diaphyseal fractures of the femur. J Bone Miner Res 27:2544, 2012
Delmas PD, Ensrud KE, Adachi JD, et al: Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. J Clin Endocrinol Metab 87(8):3609, 2002
Dennerstein L, Guthrie JR, Clark M, et al: A population-based study of depressed mood in middle-aged, Australian-born women. Menopause 11(5):563, 2004
Dennerstein L, Hayes RD: Confronting the challenges: epidemiological study of female sexual dysfunction and the menopause. J Sex Med 2(Suppl 3):118, 2005
Dennerstein L, Smith AM, Morse C, et al: Menopausal symptoms in Australian women. Med J Aust 159:232, 1993
Depypere H, Inki P: The levonorgestrel-releasing intrauterine system for endometrial protection during estrogen replacement therapy: a clinical review. Climacteric 18(4):470, 2015
Diab DL, Watts NB: Bisphosphonates in the treatment of osteoporosis. Endocrinol Metab Clinic North Am 41:487, 2012
Diab DL, Watts NB: Use of drug holidays in women taking bisphosphonates. Menopause 21(2):195, 2014
Ebina K, Hashimoto J, Kashii M, et al: The effects of switching daily teriparatide to oral bisphosphonates or denosumab in patients with primary osteoporosis. J Bone Miner Metab 35(1):91, 2017
Elraiyah T, Sonbol MB, Wang Z, et al: Clinical review: the benefits and harms of systemic dehydroepiandrosterone (DHEA) in postmenopausal women with normal adrenal function: a systematic review and meta-analysis. J Clin Endocrinol Metab 99(10):353, 2014
Emmerson E, Hardman MJ: The role of estrogen deficiency in skin ageing and wound healing. Biogerontology 13(1):3, 2012
Eriksen B: A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 180(5):1072, 1999
Erlik Y, Meldrum DR, Judd HL: Estrogen levels in postmenopausal women with hot flashes. Obstet Gynecol 59:403, 1982
Espeland MA, Stefanick ML, Kritz-Silverstein D, et al: Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators. J Clin Endocrinol Metab 82:1549, 1997
Ettinger B, Black DM, Mitlak BH, et al: Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282(7):637, 1999
Ettinger B, Ensrud KE, Wallace R, et al: Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial. Obstet Gynecol 104(3):443, 2004
Faulkner KG, von Stetten E, Miller P: Discordance in patient classification using T-scores. J Clin Densitom 2:343, 1999
FitzGerald G, Compston JE, Chapurlat RD, et al: Empirically based composite fracture prediction model from the global longitudinal study of osteoporosis in postmenopausal women (GLOW). J Clin Endocrinol Metab 99(3):817, 2014
Food and Drug Administration: FDA warns against use of energy-based devices to perform vaginal ‘rejuvenation’ or vaginal cosmetic procedures: FDA safety communication. 2018. Available at: https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-efforts-safeguard-womens-health-deceptive-health-claims Accessed September 14, 2019
Franco OH, Chowdhury R, Troup J, et al: Use of plant-based therapies and menopausal symptoms: a systematic review and meta-analysis. JAMA 315(23):2554, 2016
Freedman RR, Woodward S, Sabharwal SC: Alpha 2-adrenergic mechanism in menopausal hot flushes. Obstet Gynecol 76:573, 1990
Freedman RR: Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes. Fertil Steril 70(2):332, 1998
Freedman RR: Physiology of hot flashes. Am J Hum Biol 13:453, 2001
Freeman EW, Sammel MD, Gross SA, et al: Poor sleep in relation to natural menopause: a population-based 14-year follow-up of midlife women. Menopause 22(7):719, 2015
Freeman EW, Sammel MD, Lin H, et al: Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 61(1):62, 2004
Freeman EW, Sammel MD, Lin H, et al: Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol 110(2 Pt 1):230, 2007
Gallagher JC, Rapuri PB, Haynatzki G, et al: Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers. J Clin Endocrinol Metab 87:4914, 2002
Gebbie AE, Hardman SM: Contraception in the perimenopause—old and new. Menopause Int 16(1):33, 2010
Gedmintas L, Solomon DH, Kim SC: Bisphosphonates and risk of subtrochanteric, femoral shafts, and atypical femur fracture: a systemic review and meta-analysis. J Bone Miner Res 28:1729, 2013
Gerber LM, Sievert LL, Warren K, et al: Hot flashes are associated with increased ambulatory systolic blood pressure. Menopause 14(2):308, 2007
Gibson CJ, Huang AJ, McCaw B, et al: Associations of intimate partner violence, sexual assault, and posttraumatic stress disorder with menopause symptoms among midlife and older women. JAMA Intern Med 179(1):80, 2019
Gislason T, Benediktsdottir B, Bjornsson JK, et al: Snoring, hypertension, and the sleep apnea syndrome. An epidemiologic survey of middle-aged women. Chest 103:1147, 1993
Gold EB, Bromberger J, Crawford S, et al: Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol 153:865, 2001
Gold EB, Colvin A, Avis N, et al: Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: Study of Women’s health Across the Nation. Am J Public Health 96(7):1226, 2006
Goldberg RP, Tomezsko JE, Winkler HA, et al: Anterior or posterior sacrospinous vaginal vault suspension: long-term anatomic and functional evaluation. Obstet Gynecol 98:199, 2001
Gonzales GF, Carrillo C: Blood serotonin levels in postmenopausal women: effects of age and serum oestradiol levels. Maturitas 17:23, 1993
Gracia CR, Freeman EW, Sammel MD, et al: Hormones and sexuality during transition to menopause. Obstet Gynecol 109(4):831, 2007
Greenspan SL, Myers ER, Kiel DP, et al: Fall direction, bone mineral density, and function: risk factors for hip fracture in frail nursing home elderly. Am J Med 104(6):539, 1998
Grindler NM, Santoro NF: Menopause and exercise. Menopause 22(12):1351, 2015
Grover CM, More VP, Singh N, et al: Crosstalk between hormones and oral health in the mid-life of women: A comprehensive review. J Int Soc Prev Community Dent 4(Suppl 1):S5, 2014
Guinot C, Malvy D, Ambroisine L, et al: Effect of hormonal replacement therapy on skin biophysical properties of menopausal women. Skin Res Technol 11:201, 2005
Guthrie JR, Dennerstein L, Taffe JR, et al: Hot flushes during the menopause transition: a longitudinal study in Australian-born women. Menopause 12(4):460, 2005
Halbreich U, Lumley LA, Palter S, et al: Possible acceleration of age effects on cognition following menopause. J Psychiatr Res 29:153, 1995
Hale GE, Zhao X, Hughes CL, et al: Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system. J Clin Endocrinol Metab 92(8):3060, 2007
Hall MH, Matthews KA, Kravitz HM, et al: Race and financial strain are independent correlates of sleep in midlife women: the SWAN sleep study. Sleep 32:73, 2009
Handa VL, Harvey L, Cundiff GW, et al: Sexual function among women with urinary incontinence and pelvic organ prolapse. Am J Obstet Gynecol 191:751, 2004
Harlow SD, Gass M, Hall JE, et al: Executive summary of the Stages of Reproductive Again Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Fertil Steril 97:843, 2012
Harris SS, Dawson-Hughes B: Caffeine and bone loss in healthy postmenopausal women. Am J Clin Nutr 60(4):573, 1994
Harris ST, Watts NB, Genant HK, et al: Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 282(14):1344, 1999
Hasselquist MB, Goldberg N, Schroeter A, et al: Isolation and characterization of the estrogen receptor in human skin. J Clin Endocrinol Metab 50(1):76, 1980
Hay DL, Poyner DR: Calcitonin gene-related peptide, adrenomedullin and flushing. Maturitas 64(2):104, 2009
Henderson VW, St John JA, Hodis HN, et al: Cognition, mood, and physiological concentrations of sex hormones in the early and late postmenopause. Proc Natl Acad Sci USA 110(50):20290, 2013
Hendrix SL, Cochrane BB, Nygaard IE, et al: Effects of estrogen with and without progestin on urinary incontinence. JAMA 293(8):935, 2005
Hodis HN, Mack WJ, Henderson VW, et al: Vascular effects of early versus late postmenopausal treatment with estradiol. N Engl J Med 374(13):1221, 2016
Hollander LE, Freeman EW, Sammel MD, et al: Sleep quality, estradiol levels, and behavioral factors in late reproductive age women. Obstet Gynecol 98: 391, 2001
Holroyd C, Cooper C, Dennison E: Epidemiology of osteoporosis. Best Pract Res Clin Endocrinol Metab 22(5):671, 2008
Howe TE, Shea B, Dawson LJ, et al: Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev 7: CD000333, 2011
Hunter MS, Gentry-Maharaj A, Ryan A, et al: Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross-sectional cohort study of 10,418 British women aged 54–65. BJOG 119(1):40, 2012
Imtiaz B, Tuppurainen M, Rikkonen T, et al: Postmenopausal hormone therapy and Alzheimer disease: a prospective cohort study. Neurology 88(11): 1062, 2017
Islam RM, Bell RJ, Green S, et al: Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol 7(10):754, 2019
Ismail SI, Bain C, Hagen S: Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women. Cochrane Database Syst Rev 9: CD007063, 2010
Jaakkola S, Lyytinen H, Pukkala E, et al: Endometrial cancer in postmenopausal women using estradiol-progestin therapy. Obstet Gynecol 114(6):1197, 2009
Jackson RD, LaCroix AZ, Gass M, et al: Women’s health initiative investigators. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354(7):669, 2006a
Jackson RD, Wactawski-Wende J, LaCroix AZ, et al: Women’s health initiative investigators. Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the women’s health initiative randomized trial. J Bone Miner Res 21(6):817, 2006b
Jackson SL, Scholes D, Boyko EJ, et al: Predictors of urinary incontinence in a prospective cohort of postmenopausal women. Obstet Gynecol 108(4):855, 2006c
Jain A, Santoro N: Endocrine mechanisms and management for abnormal bleeding due to perimenopausal changes. Clin Obstet Gynecol 48:295, 2005
Javed AA, Mayhew AJ, Shea AK, Raina P. Association between hormone therapy and muscle mass in postmenopausal women: a systematic review and meta-analysis. JAMA Netw Open 2(8):e1910154, 2019
Jayasena CN, Comninos AN, Stefanopoulou E, et al: Neurokinin B administration induces hot flushes in women. Sci Rep, 2015
Kanis JA, Johnell O, Oden A, et al: Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 12:989, 2001
Kanis JA: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 4:368, 1994
Karvonen-Gutierrez C, Kim C: Association of mid-life changes in body size, body composition and obesity status with the menopausal transition. Healthcare (Basel) 4(3):1, 2016
Kaunitz AM: Transdermal and vaginal estradiol for the treatment of menopausal symptoms: the nuts and bolts. Menopause 19(6):602, 2012
Kaunitz AM, Manson JE: Management of menopausal symptoms. Obstet Gynecol 126(4):859, 2015
Kendler DL, Marin F, Zerbini CA, et al: Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet 391(10117):230, 2018
Kerstetter JE, Looker AC, Insogna KL: Low dietary protein and low bone density. Calcif Tissue Int 66(4):313, 2000
Khosia S, Burr D, Cauley J, et al: Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22:1479, 2007
Kiebzak GM, Miller PD: Determinants of bone strength. J Bone Miner Res 18:383, 2003
Kim JH, Cho HT, Kim YJ: The role of estrogen in adipose tissue metabolism: insights into glucose homeostasis regulation. Endocr J 61(11):1055, 2014
Kingsberg SA, Krychman M, Graham S, et al: The women’s empower survey: identifying women’s perceptions on vulvar and vaginal atrophy and its treatment. J Sex Med 14(3):413, 2017
Klein NA, Illingworth PJ, Groome NP, et al: Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab 81:2742, 1996
Kostenuik PJ: Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength. Curr Opin Pharmacol 5(6):618, 2005
Krall EA, Dawson-Hughes B, Papas A, et al: Tooth loss and skeletal bone density in healthy postmenopausal women. Osteoporos Int 4:104, 1994
Kronenberg F: Hot flashes: epidemiology and physiology. Ann NY Acad Sci 592:52, 1990
Kuller LH, Lopez OL, Newman A, et al: Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology 22:13, 2003
Kushnir VA, Seifer DB, Barad DH, et al: Potential therapeutic applications of human anti-m?llerian hormone (AMH) analogues in reproductive medicine. J Assist Reprod Genet 34(9):1105, 2017
Labrie F, Archer DF, Koltun W, et al: Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. Menopause 25(11):1339, 2018
Labrie F, Belanger A, Cusan L, et al: Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 82:2396, 1997
Lanza FL, Hunt RH, Thomson AB, et al: Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women. Gastroenterology 119(3):631, 2000
Larsen ER, Mosekilde L, Foldspang A: Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res 19(3):370, 2004
Lauby-Secretan B, Scoccianti C, Loomis D, et al: Body fatness and cancer— viewpoint of the IARC Working Group. N Engl J Med 375(8):794, 2016
Laufer LR, Erlik Y, Meldrum DR, et al: Effect of clonidine on hot flashes in postmenopausal women. Obstet Gynecol 60:583, 1982
Laumann EO, Paik A, Rosen RC: Sexual dysfunction in the United States: prevalence and predictors. JAMA 281:537, 1999
LeBoeuf FJ, Carter SG: Discomforts of the perimenopause. J Obstet Gynecol Neonatal Nurs 25:173, 1996
Leder BZ, Tsai JN, Uihlein AV, et al: Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial. Lancet 386(9999):1147, 2015
Leon-Ferre RA, Novotny PJ, Wolfe EG, et al: Oxybutynin versus placebo for hot flashes: a randomized, double-blind clinical trial (ACCRU SC1603). Presented at the 41st San Antonio Breast Cancer Symposium, December 4–8, 2018
Lethaby A, Ayeleke RO, Roberts H: Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 8:CD001500, 2016
Levine KB, Williams RE, Hartmann KE: Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause 15(4 Pt 1):661, 2008
Lewis JG, McGill H, Patton VM, et al: Caution on the use of saliva measurements to monitor absorption of progesterone from transdermal creams in postmenopausal women. Maturitas 41(1):1, 2002
Lidor A, Ismajovich B, Confino E, et al: Histopathological findings in 226 women with post-menopausal uterine bleeding. Acta Obstet Gynecol Scand 65:41, 1986
Lindau ST, Schumm LP, Laumann EO, et al: A study of sexuality and health among older adults in the United States. N Engl J Med 357(8):762, 2007
Lindsay R, Gallagher JC, Kagan R, et al: Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women. Fertil Steril 92(3):1045, 2009
Lindsay R, Silverman SL, Cooper C, et al: Risk of new vertebral fracture in the year following a fracture. JAMA 285:320, 2001
Lobo RA, Pinkerton JV, Gass ML, et al: Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile. Fertil Steril 92(3):1025, 2009
Lobo RA, Rosen RC, Yang HM, et al: Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil Steril 79(6):1341, 2003
Lock M: Medicine and culture: Contested meanings of the menopause. Lancet 337:1270, 1991
Long CY, Liu CM, Hsu SC, et al: A randomized comparative study of the effects of oral and topical estrogen therapy on the lower urinary tract of hysterectomized postmenopausal women. Fertil Steril 85(1):155, 2006
Ma D, Wu L, He Z: Effects of walking on the preservation of bone mineral density in perimenopausal and postmenopausal women: a systematic review and meta-analysis. Menopause 20(11):1216, 2013
Maheux R, Naud F, Rioux M, et al: A randomized, double-blind, placebo-controlled study on the effect of conjugated estrogens on skin thickness. Am J Obstet Gynecol 170(2):642, 1994
Maki PM, Kornstein SG, Joffe H, et al: Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause 25(10):1069, 2018
Malacara JM, Perez-Luque EL, Martinez-Garza S, et al: The relationship of estrogen receptor-alpha polymorphism with symptoms and other characteristics in post-menopausal women. Maturitas 49:163, 2004
Manson JE, Aragaki AK, Rossouw JE, et al: Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women’s Health Initiative randomized trials. JAMA 318(10):927, 2017
Manson JE, Chlebowski RT, Stefanick ML, et al: Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA 310(13):1353, 2013
Manson JE, Goldstein SR, Kagan R, et al: Why the product labeling for low-dose vaginal estrogen should be changed. Menopause 21(9):911, 2014
Manson JE, Kaunitz AM: Menopause management—getting clinical care back on track. N Engl J Med 374(9):803, 2016
Manson JE, Willett WC, Stampfer MJ, et al: Body weight and mortality among women. N Engl J Med 333(11):677, 1995
Marshall D, Johnell O, Wedel H: Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254, 1996
Matthews KA, Abrams B, Crawford S, et al: Body mass index in mid-life women: relative influence of menopause, hormone use, and ethnicity. Int J Obes Relat Metab Disord 25:863, 2001
Matthews KA, Meilahn E, Kuller LH, et al: Menopause and risk factors for coronary heart disease. N Engl J Med 321:641, 1989
Matthews KA, Wing RR, Kuller LH, et al: Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women. Arch Intern Med 154:2349, 1994
McClung MR, Grauer A, Boonen S, et al: Romosozumab in postmenopausal women with low bone mineral density. N Engl J Med 370(5):412, 2014
McCoy NL, Davidson JM: A longitudinal study of the effects of menopause on sexuality. Maturitas 7:203, 1985
McKinlay SM, Brambilla DJ, Posner JG: The normal menopause transition. Maturitas 14:103, 1992
Meier RP, Perneger TV, Stern R, et al: Increasing occurrence of atypical femoral fractures associated with bisphosphonate use. Arch Intern Med 172:930, 2012
Melton LJ III, Atkinson EJ, Cooper C, et al: Vertebral fractures predict subsequent fractures. Osteoporos Int 10:214, 1999
Meyer JS, Rauch GM, Crawford K, et al: Risk factors accelerating cerebral degenerative changes, cognitive decline and dementia. Int J Geriatr Psychiatry 14:1050, 1999
Miller PD, Hattersley G, Riis BJ, et al: Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial. JAMA 316(7):722, 2016
Miller PD, Njeh CF, Jankowski LG, et al: What are the standards by which bone mass measurement at peripheral skeletal sites should be used in the diagnosis of osteoporosis? J Clin Densitom 5(Suppl):S39, 2002
Moen MH, Kahn H, Bjerve KS, et al: Menometrorrhagia in the perimenopause is associated with increased serum estradiol. Maturitas 47:151, 2004
Molnar WR: Menopausal hot flashes: their cycles and relation to air temperature. Obstet Gynecol 57:52S, 1981
Nappi RE, Palacios S, Panay N, et al: Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey. Climacteric 19(2):188, 2016
National Osteoporosis Foundation: America’s bone health: the state of osteoporosis and low bone mass in our nation. Washington, The Foundation, 2002
National Osteoporosis Foundation: Clinician’s Guide to Prevention and Treatment of Osteoporosis. Washington, National Osteoporosis Foundation, 2014
Neer RM, Arnaud CD, Zanchetta JR, et al: Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344(19):1434, 2001
Newton KM, Reed SD, LaCroix AZ, et al: Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med 145(12):869, 2006
O’Neill S, Eden J: The pathophysiology of menopausal symptoms. Obstet Gynaecol Reprod Med 22(3):63, 2011
Overlie I, Finset A, Holte A: Gendered personality dispositions, hormone values, and hot flushes during and after menopause. J Psychosom Obstet Gynaecol 23(4):219, 2002
Palma F, Xholli A, Cagnacci A: As the writing group of the AGATA study. The most bothersome symptom of vaginal atrophy: Evidence from the observational AGATA study. Maturitas 108(2):18, 2018
Paramsothy P, Harlow SD, Greendale GA, et al: Bleeding patterns during the menopausal transition in the multi-ethnic Study of Women’s Health Across the Nation (SWAN): a prospective cohort study. BJOG 121:1564, 2014
Paramsothy P, Harlow SD, Nan B, et al: Duration of the menopausal transition is longer in women with young age at onset: the multiethnic Study of Women’s Health Across the Nation. Menopause 24(2):142, 2017
Patel SR, Malhotra A, White DP, et al: Association between reduced sleep and weight gain in women. Am J Epidemiol 164(10):947, 2006
Patriarca MT, Goldman KZ, Dos Santos JM, et al: Effects of topical estradiol on the facial skin collagen of postmenopausal women under oral hormone therapy: a pilot study. Eur J Obstet Gynecol Reprod Biol 130(2):202, 2007
Pauls RN, Kleeman SD, Karram MM: Female sexual dysfunction: principles of diagnosis and therapy. Obstet Gynecol Surv 60(3):196, 2005
Pereira RI, Casey BA, Swibas TA, et al: Timing of estradiol treatment after menopause may determine benefit or harm to insulin action. J Clin Endocrinol Metab 100(12):4456, 2015
Phillips TJ, Symons J, Menon S, et al: Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women. J Am Acad Dermatol 59(3):397, 2008
Pinkerton JV, Harvey JA, Lindsay R, et al: Effects of bazedoxifene/conjugated estrogens on the endometrium and bone: a randomized trial. J Clin Endocrinol Metab 99:E189, 2014
Pinkerton JV, Harvey JA, Pan K, et al: Breast effects of bazedoxifene-conjugated estrogens: a randomized controlled trial. Obstet Gynecol 121(5):959, 2013
Pinkerton JV, Kaunitz AM, Manson JE. Not time to abandon use of local vaginal hormone therapies. Menopause 25(8):855, 2018
Pinkerton JV, Santen RJ: Managing vasomotor symptoms in women after cancer. Climacteric 13:1, 2019
Pinkerton JV, Stovall DW, Kightlinger RS: Advances in the treatment of menopausal symptoms. Womens Health (England) 5 (4):361, 2009a
Pinkerton JV, Utian WH, Constantine GD, et al: Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/ conjugated estrogens: a randomized, controlled trial. Menopause 16:1116, 2009b
Portman DJ, Gass ML, Vulvovaginal Atrophy Terminology Consensus Conference Panel: Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. Maturitas 79(3):349, 2014
Prague JK, Roberts RE, Comninos AN, et al: Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet 389(10081):1809, 2017
Prentice RL, Pettinger MB, Jackson RD, et al: Health risks and benefits from calcium and vitamin D supplementation: Women’s Health Initiative clinical trial and cohort study. Osteoporos Int 24:567, 2013
Prestwood KM, Kenny AM, Kleppinger A, et al: Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: a randomized controlled trial. JAMA 290(8):1042, 2003
Rabley A, O’Shea T, Terry R, et al: Laser therapy for genitourinary syndrome of menopause. Curr Urol Rep 19(10):83, 2018
Rahn DD, Carberry C, Sanses TV, et al: Vaginal estrogen for genitourinary syndrome of menopause: a systematic review. Obstet Gynecol 124(6):1147, 2014
Ralston SH: Genetic control of susceptibility to osteoporosis. J Clin Endocrinol Metab 87:2460, 2002
Rance NE, Dacks PA, Mittelman-Smith MA, et al: Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: a novel hypothesis on the mechanism of hot flushes. Front Neuroendocrinol 34(3):211, 2013
Randolph JF Jr, Sowers M, Bondarenko I, et al: The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. J Clin Endocrinol Metab 90:6106, 2005
Rapkin AJ: Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment. Am J Obstet Gynecol 196(2):97, 2007
Recker RR, Davies KM, Hinders SM, et al: Bone gain in young adult women. JAMA 268:2403, 1992
Reyes FI, Winter JS, Faiman C: Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follicle-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Am J Obstet Gynecol 129:557, 1977
Richardson SJ, Senikas V, Nelson JF: Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 65:1231, 1987
Riedel-Baima B, Riedel A: Female pattern hair loss may be triggered by low oestrogen to androgen ratio. Endocr Regul 42(1):13, 2008
Riis BJ, Hansen MA, Jensen AM, et al: Low bone mass and fast rate of bone loss at menopause: equal risk factors for future fracture: a 15-year follow-up study. Bone 19:9, 1996
Robinson D, Cardozo L, Milsom I, et al: Oestrogens and overactive bladder. Neurourol Urodyn 33(7):1086, 2014
Rosen CJ: Clinical practice. Vitamin D insufficiency. N Engl J Med 364(3):248, 2011
Ross AC, Manson JE, Abrams SA, et al: The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96(1):53, 2011
Rossouw JE, Anderson GL, Prentice RL, et al: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 288(3):321, 2002
Rossouw JE, Prentice RL, Manson JE, et al: Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297(13):1465, 2007
Rubin MR, Cosman F, Lindsay R, et al: The anabolic effects of parathyroid hormone. Osteoporos Int 13(4):267, 2002
Russell RG, Watts NB, Ebetino FH, et al: Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 19(6):733, 2008
Saag KG, Petersen J, Brandi ML, et al: Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med 377(15):1417, 2017
Sabatier JP, Guaydier-Souquieres G, Laroche D, et al: Bone mineral acquisition during adolescence and early adulthood: a study in 574 healthy females 10–24 years of age. Osteoporos Int 6:141, 1996
Saccomani S, Lui-Filho JF, Juliato CR, et al: Does obesity increase the risk of hot flashes among midlife women?: a population-based study. Menopause 24(9):1065, 2017
Salonia A, Zanni G, Nappi RE, et al: Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross-sectional study. Eur Urol 45:642, 2004
Sambrook P, Cooper C: Osteoporosis. Lancet 367(9527):2010, 2006
Sanders KM, Stuart AL, Williamson EJ, et al: Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303(18):1815, 2010
Santesso N, Carrasco-Labra A, Brignardello-Petersen R: Hip protectors for preventing hip fractures in older people. Cochrane Database Syst Rev 3:CD001255, 2014
Santoro N: Perimenopause: from research to practice. J Womens Health (Larchmt) 25(4):332, 2016a
Santoro N, Braunstein GD, Butts CL, et al: Compounded bioidentical hormones in endocrinology practice: an endocrine society scientific statement. J Clin Endocrinol Metab 101:1318, 2016b
Santoro N, Brown JR, Adel T, et al: Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab 81:1495, 1996
Santoro N: The menopausal transition. Am J Med 118(12 suppl):8, 2005
Sator PG, Sator MO, Schmidt JB, et al: A prospective, randomized, double-blind, placebo-controlled study on the influence of a hormone replacement therapy on skin aging in postmenopausal women. Climacteric 10(4):320, 2007
Sauerbronn AV, Fonseca AM, Bagnoli VR, et al: The effects of systemic hormonal replacement therapy on the skin of postmenopausal women. Int J Gynaecol Obstet 68(1):35, 2000
Scheffers CS, Armstrong S, Cantineau AE, et al: Dehydroepiandrosterone for women in the peri- or postmenopausal phase. Cochrane Database Syst Rev 1:CD011066, 2015
Schiff I, Tulchinsky D, Cramer D, et al: Oral medroxyprogesterone in the treatment of postmenopausal symptoms. JAMA 244:1443, 1980
Sellmeyer DE, Schloetter M, Sebastian A: Potassium citrate prevents increased urine calcium excretion and bone resorption induced by a high sodium chloride diet. J Clin Endocrinol Metab 87(5):2008, 2002
Shams-White MM, Chung M, Du M, et al: Dietary protein and bone health: a systematic review and meta-analysis from the National Osteoporosis Foundation. Am J Clin Nutr 105(6):1528, 2017
Sherburn M, Guthrie JR, Dudley EC, et al: Is incontinence associated with menopause? Obstet Gynecol 98:628, 2001
Shifren JL, Braunstein GD, Simon JA, et al: Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 343(10):682, 2000
Shifren JL, Gass ML, NAMS Recommendations for Clinical Care of Midlife Women Working Group: The North American Menopause Society recommendations for clinical care of midlife women. Menopause 21(10):1038, 2014
Shumaker SA, Legault C, Kuller L, et al: Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women’s Health Initiative Memory Study. JAMA 291(24):2947, 2004
Shumaker SA, Legault C, Rapp SR, et al: Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial. JAMA 289(20):2651, 2003
Sideras K, Loprinzi CL: Nonhormonal management of hot flashes for women on risk reduction therapy. J Natl Compr Canc Netw 8(10):1171, 2010
Sigurdsson G, Halldorsson BV, Styrkarsdottir U, et al: Impact of genetics on low bone mass in adults. J Bone Miner Res 23(10):1584, 2008
Simon JA, Altomare C, Cort S, et al: Overall safety of ospemifene in postmenopausal women from placebo-controlled phase 2 and 3 trials. J Womens Health (Larchmt) 27(1):14, 2018
Simon JA, Lin VH, Radovich C, et al: One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus. Menopause 20(4):418, 2013
Slopien R, Meczekalski B, Warenik-Szymankiewicz A: Relationship between climacteric symptoms and serum serotonin levels in postmenopausal women. Climacteric 6:53, 2003
Smith DC, Prentice R, Thompson DJ, et al: Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 293(23):1164, 1975
Soares CN, Almeida OP, Joffe H, et al: Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 58(6):529, 2001
Soares CN: Menopause and mood disturbance. Psychiatric Times 12:2005
Soares CN: Mood disorders in midlife women: understanding the critical window and its clinical implications. Menopause 21(2)198, 2014
Sokol ER, Karram MM: Use of a novel fractional CO2 laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes. Menopause 24(7):810, 2017
Sriprasert I, Hodis HN, Karim R, et al: Differential effect of plasma estradiol on subclinical atherosclerosis progression in early vs late postmenopause. J Clin Endocrinol Metab 104(2):293, 2019
Stear SJ, Prentice A, Jones SC, et al: Effect of a calcium and exercise intervention on the bone mineral status of 16- to 18-year-old adolescent girls. Am J Clin Nutr 77:985, 2003
Stein E, Shane E: Secondary osteoporosis. Endocrinol Metab Clin North Am 32:115, 2003
Sternfeld B, Wang H, Quesenberry CP Jr, et al: Physical activity and changes in weight and waist circumference in midlife women: findings from the Study of Women’s Health Across the Nation. Am J Epidemiol 160(9):912, 2004
Tashjian AH Jr, Chabner BA: Commentary on clinical safety of recombinant human parathyroid hormone 1–34 in the treatment of osteoporosis in men and postmenopausal women. J Bone Miner Res 17(7):1151, 2002
Tepper PG, Brooks MM, Randolph JF Jr, et al: Characterizing the trajectories of vasomotor symptoms across the menopausal transition. Menopause 23(10):1067, 2016
The North American Menopause Society: Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause 17(1):25, 2010
The North American Menopause Society: Management of symptomatic vulvovaginal atrophy: 2013 position statement of the North American Menopause Society. Menopause 20(9):888, 2013
The North American Menopause Society: The 2017 hormone therapy position statement of The North American Menopause Society. Menopause 24(7):728, 2017
The North American Menopause Society: Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause 22(11):1155, 2015
The Women’s Health Initiative Steering Committee: Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women’s Health Initiative Randomized Controlled Trial. JAMA 291:1701, 2004
Theintz G, Buchs B, Rizzoli R, et al: Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab 75:1060, 1992
Thornton MJ: Estrogens and aging skin. Dermatoendocrinol 5(2):264, 2013
Thurston RC, Bromberger JT, Joffe H, et al: Beyond frequency: who is most bothered by vasomotor symptoms? Menopause 5:841, 2008
Thurston RC, Sowers MR, Sternfeld B, et al: Gains in body fat and vasomotor symptom reporting over the menopausal transition: the study of women’s health across the nation. Am J Epidemiol 170(6):766, 2009
Tosteson AN, Melton LJ III, Dawson-Hughes B, et al: Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 19(4):437, 2008
Treloar AE: Menstrual cyclicity and the pre-menopause. Maturitas 3(3-4):249, 1981
Trutnovsky G, Rojas RG, Mann KP, et al: Urinary incontinence: the role of menopause. Menopause 21(4):399, 2014
Tungphaisal S, Chandeying V, Sutthijumroon S, et al: Postmenopausal sexuality in Thai women. Asia Oceania J Obstet Gynaecol 17:143, 1991
US Census Bureau: 2017 national population projections tables. 2017. Available at: https://www.census.gov/data/tables/2017/demo/popproj/2017- summary-tables.html. Accessed September 1, 2019
US Preventive Services Task Force, Grossman DC, Curry SJ, et al: Interventions to prevent falls in community-dwelling older adults: US Preventive Services Task Force recommendation statement. JAMA 319(16):1696, 2018a
US Preventive Services Task Force, Grossman DC, Curry SJ, et al: Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults: US Preventive Services Task Force recommendation statement. JAMA 319(15):1592, 2018b
US Preventive Services Task Force, Owens DK, Davidson KW, et al: Medication use to reduce risk of breast cancer: US Preventive Services Task Force recommendation statement. JAMA 322(9):857, 2019
Utian W, Yu H, Bobula J, et al: Bazedoxifene/conjugated estrogens and quality of life in post-menopausal women. Maturitas 63:329, 2009
Van Beresteijn EC, Korevaar JC, Huijbregts PC, et al: Perimenopausal increase in serum cholesterol: a 10-year longitudinal study. Am J Epidemiol 137:383, 1993
Vinogradova Y, Coupland C, Hippisley-Cox J: Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ 364:k4810, 2019
Waetjen LE, Ye J, Feng WY, et al: Association between menopausal transition stages and developing urinary incontinence. Obstet Gynecol 114(5):989, 2009
Walker MD, Liu XS, Stein E, et al: Differences in bone microarchitecture between postmenopausal Chinese-American and white women. J Bone Miner Res 26:1392, 2011
Watts NB, Cauley JA, Jackson RD, et al: Women’s Health Initiative Investigators. No increase in fractures after stopping hormone therapy: results from the women’s health initiative investigators. J Clin Endocrinol Metab 102(1):302, 2017
Wells G, Tugwell P, Shea B, et al: Metaanalyses of therapies for postmenopausal osteoporosis. V. Metaanalysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev 23:529, 2002
Whitaker M, Guo J, Kehoe T, Benson G. Bisphosphonates for osteoporosis— where do we go from here? N Engl J Med 366:2048, 2012
Wierman ME, Arlt W, Basson R, et al: Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 99(10):3489, 2014
Wilbur J, Miller AM, Montgomery A, et al: Sociodemographic characteristics, biological factors, and symptom reporting in midlife women. Menopause 5:43, 1998
Wines N, Willsteed E: Menopause and the skin. Australas J Dermatol 42:149, 2001
Wing RR, Matthews KA, Kuller LH, et al: Weight gain at the time of menopause. Arch Intern Med 151:97, 1991
Woods NF, Smith-DiJulio K, Percival DB, et al: Depressed mood during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women’s Health Study. Menopause 15(2):223, 2008
Woodward S, Freedman RR: The thermoregulatory effects of menopausal hot flashes on sleep. Sleep 17:497, 1994
Yaffe K, Sawaya G, Lieberburg I, et al: Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 279(9):688, 1998
Yaghjyan L, Colditz GA: Estrogens in the breast tissue: a systematic review. Cancer Causes Control 22(4):529, 2011
Zaitlen N, Kraft P, Patterson N, Using extended genealogy to estimate components of heritability for 23 quantitative and dichotomous traits. PLoS Genet 9(5):e1003520, 2013
Zandi PP, Carlson MC, Plassman BL, et al: Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288(17):2123, 2002
Zava DT, Dollbaum CM, Blen M: Estrogen and progestin bioactivity of foods, herbs, and spices. Proc Soc Exp Biol Med 217(3):369, 1998
Zoltick ES, Sahni S, McLean RR, et al: Dietary protein intake and subsequent falls in older men and women: the Framingham Study. J Nutr Health Aging 15(2):147, 2011
Zweifel JE, O’Brien WH: A metaanalysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 22(3):189, 1997
